NCT00354393 2025-07-15
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
The Cleveland Clinic
Phase 2 Completed
Clinical Trials
14 trialsNCT02555007 2022-11-17
NVB Metro
Assistance Publique Hopitaux De Marseille
Phase 1 Completed
NCT02139904 2021-10-12
VIM
Wales Cancer Trials Unit
Phase 2 Completed
NCT02610140 2020-11-04
Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
Bayer
Phase 2 Completed
NCT00958724 2018-06-28
Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00597116 2016-10-10
An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma
Sanofi
Phase 2 Terminated
NCT00006088 2013-09-20
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00030459 2013-08-07
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00075699 2013-08-07
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
National Cancer Institute (NCI)
Phase 3 Completed
NCT00389922 2012-04-19
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
University of California, Davis
Phase 1 Completed
NCT01220284 2010-10-13
Satraplatin and Vinorelbine in Advanced Solid Tumors
Southern Europe New Drug Organization
Phase 1 Unknown
NCT00006372 2010-06-11
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00801151 2010-05-20
Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer
Institut Claudius Regaud
Phase 1 Terminated
NCT00272558 2009-09-18
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
Rigshospitalet, Denmark
Phase 2 Completed